We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

The Odyssey of Modern Drug Research: Pharmaceutical Manufacture; its Science and Economics

JAMA. 1951;147(15):1506. doi:10.1001/jama.1951.03670320106041.
Text Size: A A A
Published online


The story of the development of modern therapeutic agents is too often inadequately appreciated. Vaguely, we know that someone discovers them, others study their action and determine their usefulness, and still others make them available for prescription use. This book presents, in sufficient detail, the story of the discovery and development of some of these agents. No one can follow it without gaining a greater respect for this triad of workers, whose combined efforts have resulted in our modern chemotherapeutic drugs.

The author has chosen certain illustrative examples of such agents, and their detailed story affords entertaining and informative reading. He offers the facts behind the discovery and development of the antibiotics, the sulfonamides, and the adrenocortical steroids and also presents the essential part that modern pharmaceutical companies have played in making them available. Also presented is an altogether engaging glance behind the scenes in a discussion of anticipated developments


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.